Moreover, p53 mutation shortens the latency and increases the frequency of PDAC formation in mouse pancreatic tumour models in which p53 is simultaneously mutated at the time of oncogenic Kras activation13, 20. The gene discussed is KRAS; the disease is pancreatic neoplasm.